Perjeta Coupon: Save $4,000 Per Year On New Breast Cancer Drug

PERJETA™ (pertuzumab) is an exciting new breast cancer drug from Genentech, a leading California biotech company. It has been shown to extend the life of a breast cancer patient by up to 6 months!

It is very effective BUT it is very expensive, costing about $80,000 per patient treatment. Add this to the fact that it is often used in combination with Herception, which costs about $100,000 per patient treatment.

Genentech is making it easier for patients to afford PERJETA™ (pertuzumab) by subsidizing co-insurance with an outstanding drug coupon offer known as the Genentech BioOncology™Co-pay Card. This valuable coupon is also valid for 8 other drugs :)

The way it works is that for patients with family incomes less than $150,000 per year, Genentech will pay for 80% of your out-of-pocket costs up to $4,000 per year. If your family income is more than $150,000 per year, they will pay up to $1,500 per year.

Click HERE to learn more about the Perjenta™Printable Coupon Co-pay Card, as described above.

Click HERE to learn more about the Genentech BioOncology™Co-pay Card, as described above.

See Also:Genentech BioOncology™Co-pay Card forAvastin|Herceptin|Rituxan|Erivedge|Tarceva|Xeloda|Zelboraf.